Floatz logo

CLORAZEPIC ACID

Migraine With Aura

Assistance Publique - Hôpitaux de ParisSmall moleculePhase 3Dormant
CCC
55/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
81/ 100

Competitive context

22 Active assets in the Migraine With Aura cohort.

Asset / SponsorPhaseRating
Topamax
Tongji Hospital
Phase 4BBB
Dihydroergotamine mesylate
Satsuma Pharmaceuticals, Inc.
Phase 3BB
PROPRANOLOL
Norwegian University of Science and Technology
Phase 3BB
Rimegepant
University of South Florida
Phase 4BB
ALMOTRIPTAN
Messoud Ashina, MD
Phase 4BB

View all 49 →

Same molecule, other indications

CLORAZEPIC ACID is also rated in:

migraine without auraDormant
B
Indicative ·
57 / 100
View asset →
headache disorderDormant
B
Indicative ·
57 / 100
View asset →
migraine disorderDormant
CCC
Indicative ·
52 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →